Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus [2]

Indian Journal of Medical Research

Volumn 123, Issue 4, 2006, Pages 571-573

  Gadepalli, Ravisekhar ^a   Dhawan, Benu ^a   Mohanty, Srujana ^a   Kapil, Arti ^a   Das, Bimal K ^a   Chaudhry, Rama ^a  

^a All India of Medical Sciences ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; METICILLIN; PENICILLIN BINDING PROTEIN 2A; STREPTOGRAMIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; IN VITRO STUDY; INDIA; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PROTEIN ANALYSIS; STAPHYLOCOCCUS AUREUS; TERTIARY HEALTH CARE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33745456193     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Delialioglu N, Aslan G, Ozturk C, Baki V, Sen S, Emekdas G. Inducible clindamycin resistance in staphylococci isolated from clinical samples. Jpn J Infect Dis 2005; 58 : 104-6.
2. Fokas S, Fokas S, Tsironi M, Kalkani M, Diony Sopouloy M. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin Microbiol Infect 2005; 11 : 337-40.
3. Azap ÖK, Arslan H, Timurkaynak F, Yapar G, Oruc E, Gagir U. Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey. Clin Microbiol Infect 2005; 11 : 582-4.
4. Steward CD, Raney PM, Morrell AK, Williams PP, McDougal LK, Jevitt L, et al. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J Clin Microbiol 2005; 43 : 1716-21.
5. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41 : 4740-4.
6. Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001; 48 : 315-6.
7. Baird D. Staphylococcus: cluster-forming Gram-positive cocci. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie & McCartney practical medical microbiology, 14th ed. New York: Churchill Livingstone; 1996 p. 245-61.
8. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A7, 11th ed. 2005; Wayne, Pa.
9. Perez-Roth E, Claverie-Martin F, Batista N, Moreno A, Mendez-Alvarez S. Mupirocin resistance in methicillin-resistant Staphylococcus aureus clinical isolates in a Spanish hospital. Co-application of multiplex PCR assay and conventional microbiology methods. Diagn Microbiol Infect Dis 2002; 43 : 123-8.
10. Bradley JR. Newer antistaphylococcal agents. Curr Opin Pediatr 2005; 17 : 71-7.